Board of Directors

Board of Directors

Gisela Sitbon

Chairperson of the board. Board member since 2012, Chairperson since 2014

Education and training:

Doctorate in medical sciences from the Karolinska Institute in Solna

Main experience:

Twenty-five years of experience in the life science industry, of which just over ten years in senior positions (including CEO) at Professional Genetics Laboratory AB and five years as head of section at Karo Bio AB. Business coach in the life science sector at STING AB and responsible for business development for growth companies at her own company ZENZ AB.

Other board appointments:

Chairperson of the board Beactica AB, board member of CollaboDoc AB, Annexin Pharmaceuticals AB and Sitbon Bioscience Partner Zenz AB

Holds 20,000 shares through the company Sitbon Bioscience Partner Zenz AB

Hans Lennernäs

Board member since 2014                                                          

Education and training:

Doctorate in pharmacy from Uppsala University           

Main experience:

Professor of Biopharmacy at the Department of Pharmacy, Uppsala University. Co-founder of, among others, DuoCort Pharma AB and LIDDS AB.

 

Other board appointments:

Chairperson of the board CanThera AB, board member of Hans Lennernäs Biomedical AB and Empros Pharma AB

Holds 6,000 shares through the company Hans Lennernäs Biomedical AB

Lena Torlegård

Board member since 2014

Education and training:

Bachelor of Science in business administration from the Stockholm School of Economics

Main experience:

More than 20 years of experience as a communications consultant for companies in the life science sector. Senior consultant at Springtime-Intellecta AB in Stockholm where she primarily works with financial and corporate communications but also with crisis management and trademark issues.

Other board appointments:

Board member of CoDesign Sweden AB, Annexin Pharmaceuticals AB, IRLAB Therapeutics AB and Lena Torlegård AB

Holds 3,739 shares

Eva Byröd

Board member since 2017

Education and training:

Master of Science in Chemical Engineering Chalmers University of Technology

Main experience:

More than twenty-five years of experience as a line manager in pharmaceutical research and development and ten years’ experience as a Project Manager/Project Director, working in early as well as late phase pharmaceutical development projects.                                                                                          

Other board appointments:

Board member of Eva Byröd Consulting AB and Bo Karlberg Arkitektur & Utveckling AB

Holds no shares in Nanologica

Mattias test

Mattias Bengtsson

Board member since 2019

Education and training:

Master of Science in Chemical Engineering at Chalmers University of Technology in Gothenburg,  MBA at University of Gothenburg School of Business

Main experience:

More than 15 years of experience from AkzoNobel Pulp and Performance Chemicals AB, as General Manager Kromasil and Fine Chemicals, Manager Global Sales and Marketing, Manufacturing Manager and Product Category Manager. Currently CEO of Biolin Scientific AB.

Other board appointments:

No other appointments

Holds no shares in Nanologica